Straight 8 mm downcutting Royce blade. Can be placed in closed handle for protection. Rigid handle when folded and locked. Straight 8 mm downcutting blades. Handle length folded 109 mm, 4.3 inches.
Duckbill. 3.5 mm tip. Light curve.
2 mm. Angled 13 degrees, 15 mm from angle to tip. Round handle.
2 mm curved tip. Round handle. Designated most popular model or size.
Medicine Products:(Date:7/25/2008)...fense and Federal Agencies in, the execution of O...is a, four-day, multi-agency collaborative train...ocal agencies with large and complex incident resp...ad-hoc, secure mobile communications infrastruct..., Va., July 25 /PRNewswire/ -- Dataline LLC is ple...
(Date:7/25/2008)... J. Reilly, Joins Aethon Team, PITTSBURGH, July 2...com ), the leading developer of mobile robotics fo... that Robert J. Reilly has,joined the company as S... Reilly, who was most recently Vice President -- G...y Pharmacy Division, brings more than 30,years of ...
(Date:7/25/2008)...e presented at Fenway Park ...swire/ -- CVS/pharmacy announced today,that this y...n just 21 days,through its annual in-store fundrai...h year of the annual fundraising effort which, to ...earch. This year,s fundraiser took,place in CVS/ph...
(Date:7/25/2008)...rop pounds, study finds , , FRIDAY, July...day morning weigh-ins knows this unalterable truth...searchers have some science to back up dieters, co...people do eat more on the weekend, even when they,...s can wreak havoc on weight control, either causin...
Breaking Medicine News(10 mins):Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3Health News:Aethon, Inc. Names New Chief Financial Officer 2Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2Health News:Weekends Tough on the Diet 2Health News:Weekends Tough on the Diet 3(Date:7/23/2008)...LE, July 23 /- Sound Pharmaceuticals ...ation with the FDA for the clinical,testing of a p...on of,chemotherapy induced hearing loss or ototoxi...5, will be tested in advanced stage lung cancer,an... based chemotherapy.,This marks the second develop...
(Date:7/23/2008)...Study Finds Some Areas of the Body Have Greater Co...l., July 23 /PRNewswire-USNewswire/ -- Fat removed...posuction was found to be,an excellent source of s...an other areas of the body, reports a Brazilian-ba...urgery(R), the official medical journal of the,Ame...
(Date:7/23/2008)...ny Focused on IND-Enabling Work with Protein Thera...y of Complement System, CAMBRIDGE, Mass., July 23...nnounced it has initiated a corporate growth plan ...chief executive officer and the,establishment of i...ucceeds,Woodruff Emlen, M.D., a co-founder of the ...
(Date:7/22/2008)...APOLIS, July 22 /- Nonin Medical, a l...ions for more than 20 years, has entered,the clini... to measure,regional oxygen saturation. Today,s mo...ontinuous monitoring of the regional blood oxygena...sting data and outcomes from an ongoing clinical s...
Breaking Medicine Technology:Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2Drs John Patton of Nektar Igor Gonda of Aradigm Tomas Landh of Novo Nordisk Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas 622 1Drs John Patton of Nektar Igor Gonda of Aradigm Tomas Landh of Novo Nordisk Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas 622 2Drs John Patton of Nektar Igor Gonda of Aradigm Tomas Landh of Novo Nordisk Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas 622 3Luminex Corporation to Present at ThinkEquity Partners Investor Conference 619 1Luminex Corporation to Present at ThinkEquity Partners Investor Conference 619 2Mouthpiece Could Help Ease Snoring 1395 1Mouthpiece Could Help Ease Snoring 1395 2Actavis Confirms its Patent Challenge of Kings Avinza 28R 29 1393 1Actavis Confirms its Patent Challenge of Kings Avinza 28R 29 1393 2.../PRNewswire/ -- Results from analyses,looking at...,ulcerative colitis (UC), were presented at Digest...studies were funded by Procter &,Gamble (P&G) Ph...r new information on improvement of quality of lif...mine), which is from a class,of agents known as ...
... 2007 /PRNewswire/ -- A three-year,follow-up sub...clinical trial at EuroPCR 2007 showed that the CYP...lts comparable to coronary,artery bypass graftin...han bare metal stents (BMS) in diabetic patients w..., The CYPHER(R) Stent results in the diabetic po...
Other Medicine Technology:Separate Sets of Research Show Treatment Improved Quality of Life,in as Early as Three Weeks; Patient Adherence to Medication is,Multifactorial 2Separate Sets of Research Show Treatment Improved Quality of Life,in as Early as Three Weeks; Patient Adherence to Medication is,Multifactorial 3Separate Sets of Research Show Treatment Improved Quality of Life,in as Early as Three Weeks; Patient Adherence to Medication is,Multifactorial 4Separate Sets of Research Show Treatment Improved Quality of Life,in as Early as Three Weeks; Patient Adherence to Medication is,Multifactorial 5Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to,Bypass Surgery and Better Outcomes Than Bare Metal Stents in,Subgroup Analysis of Diabetic Patients With Multivessel Coronary,Disease 2Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to,Bypass Surgery and Better Outcomes Than Bare Metal Stents in,Subgroup Analysis of Diabetic Patients With Multivessel Coronary,Disease 3Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to,Bypass Surgery and Better Outcomes Than Bare Metal Stents in,Subgroup Analysis of Diabetic Patients With Multivessel Coronary,Disease 4